<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230815059152N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-11</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of intravenous iron injection in spine surgery</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the relationship between intravenous iron injection before spinesurgery in patients and improving perioperative outcomes, a randomized clinical trila.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-05-24</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72269</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Double blinded, Placebo: Not used, Assignment: Other, Purpose: Treatment, Blinding description: The aforementioned study is a double-blind clinical trial, as follows:
1) The statistical analyst is outside the treatment team, and it is not clear to them whether group A, B or C has been subjected to intervention and the information of each of the three groups without being told in which of the groups the intervention took place. has been accepted and will be available to them.
 2) The neurosurgery assistant present during the operation, (who is present as a clinical supervisor)so that all three groups of patients will undergo posterior instrumentation surgery, as well as the same surgical technique and the possibility of deviation by the surgeon during the operation, they are informed that this The patients are in the study, but they are not told which of the patients have undergone intravenous iron injection and intervention.</study_design>
      <phase>3</phase>
      <hc_freetext>After posterior fusion surgery of lumbar vertebrae.</hc_freetext>
      <i_freetext>The patients in the mentioned clinical trial study are in three groups (A), (B) and (C). All the patients who entered the Madaleh have signed a written consent form to perform the intervention and have received full explanations. Group (a) are those patients who have anemia in laboratory results before surgery, i.e. hemoglobin less than 13 gm/dL for men and less than 12 mg/dL for women. and they are supposed to undergo the intervention of intravenous iron injection. Group (b) are those patients who do not have anemia in laboratory tests before surgery and are supposed to undergo the intervention of intravenous iron injection,Group (c) is the control group that does not undergo the intervention of intravenous iron injection.Venofer intravenous iron comes in the form of vials containing 500 mg of iron, which is injected into the patient in 1000 cc of normal saline over a period of 15 minutes to 1 hour. Intravenous iron injection is done 24 hours before surgery in these patients. Before the injection, the patients' hemoglobin and ferritin levels are checked and recorded in laboratory tests. After surgery, laboratory tests are repeated at intervals of 1 day, 14 days, and then 28 days, and their levels are also recorded. Also, during hospitalization, patients are checked for the occurrence of infection at the operation site and also the duration of hospitalization. On the 28th day, the patients undergo a routine follow-up CT scan or a simple photo of the abdomen, and with the help of the Lenke criteria, we can classify the degree of swelling of the patients.All information and data are presented to a statistical expert for analysis. It should be noted that the statistical analyst is outside the treatment team and is blinded to the intervention. Also, neurosurgery assistants who are present during the surgery to prevent bias. The precision and technique during the operation is blind to the intervention..</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Duration of hospitalization from before operation to after
Number of operated tubes
Is there an infection at the surgical site or not?
What was the initial and final hemoglobin level? Has it dropped or not? Are the changes meaningful?

When:
From 1403

To whom:
Researchers working in academic institutions

Conditions:
Natural and legal persons with university faculty status

Where to obtain:
Farzan Fahim, mobile number 09120943182, email address farzn.fahim@gmail.com

How to obtain:
First, send an email with your complete introduction, then the answer will be sent within 24 hours.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>farzan fahim</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nirvana Building, No. 1, corner of 16th St., in front of the fire station, Volenjak St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985743855</zip>
        <telephone>+98 21 2680 0765</telephone>
        <email>farzn.fahim@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>farzan fahim</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nirvana Building, No. 1, corner of 16th St., in front of the fire station, Volenjak St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985743855</zip>
        <telephone>+98 21 2680 0765</telephone>
        <email>farzn.fahim@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age range from 18 to 70years
Patients undergoing posterior vertebral fusion surgery at least 3 levels</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of iron sensitivity
Under 18 years and over 70 years
known Cirrhosis of the liver
known  Thalassemia major
Ferritin more than 300 ng/dl
known  Thalassemia Intermedia
known  Hemosiderosis
known  Active phase of nutritional deficiency</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The patients in the mentioned clinical trial study are in three groups (A), (B) and (C). All the patients who entered the Madaleh have signed a written consent form to perform the intervention and have received full explanations. Group (a) are those patients who have anemia in laboratory results before surgery, i.e. hemoglobin less than 13 gm/dL for men and less than 12 mg/dL for women. and they are supposed to undergo the intervention of intravenous iron injection. Group (b) are those patients who do not have anemia in laboratory tests before surgery and are supposed to undergo the intervention of intravenous iron injection,Group (c) is the control group that does not undergo the intervention of intravenous iron injection.Venofer intravenous iron comes in the form of vials containing 500 mg of iron, which is injected into the patient in 1000 cc of normal saline over a period of 15 minutes to 1 hour. Intravenous iron injection is done 24 hours before surgery in these patients. Before the injection, the patients' hemoglobin and ferritin levels are checked and recorded in laboratory tests. After surgery, laboratory tests are repeated at intervals of 1 day, 14 days, and then 28 days, and their levels are also recorded. Also, during hospitalization, patients are checked for the occurrence of infection at the operation site and also the duration of hospitalization. On the 28th day, the patients undergo a routine follow-up CT scan or a simple photo of the abdomen, and with the help of the Lenke criteria, we can classify the degree of swelling of the patients.All information and data are presented to a statistical expert for analysis. It should be noted that the statistical analyst is outside the treatment team and is blinded to the intervention. Also, neurosurgery assistants who are present during the surgery to prevent bias. The precision and technique during the operation is blind to the intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Duration of hospitalization after surgery. Timepoint: The beginning of the study and the end of the study. Method of measurement: Counting down the days.</prim_outcome>
      <prim_outcome>Incidence of infection. Timepoint: Day 0 until the end of hospitalization. Method of measurement: Qualitative.</prim_outcome>
      <prim_outcome>The degree of fusion of the vertebrae with an interval of one month after the operation. Timepoint: one month after the operation. Method of measurement: lenke scale.</prim_outcome>
      <prim_outcome>Hemoglobin drop after surgery. Timepoint: Immediately after surgery, 14 days and then 28 days after surgery. Method of measurement: laboratory.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-08-27</approval_date>
        <contact_name>Ethics Committee of Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>Volenjek St., in front of the fire station, corner of 16th St., Nirvana Building, No. 1 Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
